Menu
Not yet recruiting NCT07246603

Virtual Housecalls: Redesigning Pediatric Primary Care Adolescent Obesity Treatment

No phase Interventional Class I Obesity Pediatric Obesity

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Virtual Housecalls.
Who it may be relevant to
Registry conditions: Class I Obesity, Pediatric Obesity. Basic parameters: 12 years — 15 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

This pragmatic randomized clinical trial tests a novel intensive health behavior and lifestyle intervention, conducted via telehealth, to treat class I adolescent obesity in pediatric primary care. Results will inform scalable approaches that meet the recommended treatment dose and effectively treat obesity in this setting.

Detailed description

This trial will test Virtual Housecalls (VHC) in a pragmatic randomized clinical trial with 250 adolescents ages 12-15 years with class 1 (non-severe) obesity (BMI≥95% and \<120% of the 95%) and a participating parent/caregiver (N=250 dyads / 500 individuals). VHC includes 26 hours of treatment, by combining in-person PPCP visits (every 3m) with 6m of virtual visits conducted by a behavior coach (3m weekly, 3m every 2 weeks), and weekly exercise videos. The control arm will receive enhanced treatment as usual (TAU+), which includes usual care by their pediatric primary care practitioner (PPCP), augmented with publicly available education, sent on an attention-matched contact schedule. All PPCPs will receive training on the AAP Clinical Practice Guideline for obesity treatment and reports of participant progress at 3, 6, and 12m. Assessments of anthropometrics, dietary intake, physical activity, parenting and the home environment will be completed at 0, 3, 6 (post-intervention), and 12m (maintenance), with the primary endpoint at 6m. The investigators will evaluate the efficacy of VHC on adolescent change in body mass index (primary outcome) and dietary and physical activity behaviors (secondary outcomes). Investigators will also evaluate how treatment dose impacts BMI reduction.

Interventions

  • Behavioral Virtual Housecalls
    26 contact hours of evidence-based intensive health and behavioral lifestyle treatment, as per the American Academy of Pediatrics Clinical Practice Guidelines

Primary outcome measures

  • Body Mass Index (BMI) Change [Time frame: 0 - 6 months]
Secondary outcome measures (5)
  • Body Mass Index (BMI) Maintenance [Time frame: 6 - 12 months]
  • Energy Intake [Time frame: 0-6-months, 6-12-months]
  • Diet Quality [Time frame: 0-6-months, 6-12-months]
  • Physical Activity [Time frame: 0-6-months, 6-12-months]
  • Treatment Dose [Time frame: 0-6-months]

Eligibility criteria

Adolescent Inclusion Criteria:

  • English or Spanish-speaking
  • 12-15 years of age
  • Receiving care at a participating clinic
  • Body Mass Index (BMI) ≥95% and <120% of the 95%
  • Access to a mobile device with a webcam that can receive texts

Parent Inclusion Criteria:

  • English or Spanish-speaking
  • Primary legal guardian ≥18 years of age living with the adolescent

Exclusion criteria

  • conflicts that would inhibit the ability to participate in all aspects of the study as outlined in the study protocol
  • family plans to move outside of the study area or plans to no longer be a patient at a participating clinic in the 12 month study period
  • the primary care provider or PI determines that the study is not clinically or medically appropriate (e.g., significant psychiatric, cognitive, physical or developmental conditions that would impair their ability to complete assessments, participate in study sessions, or conduct physical activity) based on screening at study onset
  • adolescent exhibits severe dietary restriction or compensatory behavior (e.g., vomiting, laxative abuse) based on screening at study onset and clinical interview by a study psychologist
  • adolescent is currently pregnant/plans to become pregnant during study period
  • adolescent is participating in another weight loss program, has had or plans to undergo weight loss surgery
  • adolescent has a chronic medical condition(s) and/or uses medication that substantially impacts or interferes with growth, appetite, weight or physical activity participation
  • adolescents taking anti-obesity medication are ineligible if they are not a stable dose for at least 3 months prior to study participation

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Treatment

Study locations

United States · 1 center
  • Children's Hospital of Richmond at VCU Healthy Lifestyles Center — Henrico

Identifiers

NCT: NCT07246603 · HM300000084 · R01DK144911

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗